Search Results - "Østergaard, Kamilla"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Extended interval dosing with ocrelizumab in multiple sclerosis by Novak, Frederik, Bajwa, Hamza Mahmood, Østergaard, Kamilla, Berg, Jonas Munksgaard, Madsen, Jonna Skov, Olsen, Dorte Aalund, Urbonaviciute, Inga, Illes, Zsolt, Stilund, Morten Leif, Romme Christensen, Jeppe, Bramow, Stephan, Sellebjerg, Finn, Sejbaek, Tobias

    Published in Multiple sclerosis (01-06-2024)
    “…Background: This study investigates clinical and biomarker differences between standard interval dosing (SID) and extended interval dosing (EID) of ocrelizumab…”
    Get full text
    Journal Article
  2. 2

    Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke by Clausen, Bettina H, Wirenfeldt, Martin, Høgedal, Sofie S, Frich, Lars H, Nielsen, Helle H, Schrøder, Henrik D, Østergaard, Kamilla, Finsen, Bente, Kristensen, Bjarne W, Lambertsen, Kate L

    Published in Acta neuropathologica communications (05-06-2020)
    “…Preclinical and clinical proof-of-concept studies have suggested the effectiveness of pharmacological modulation of inflammatory cytokines in ischemic stroke…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Long-term use of antiplatelet drugs by patients with transient ischaemic attack by Østergaard, Kamilla, Madsen, Charlotte, Liu, Marie-Louise, Bak, Søren, Hallas, Jesper, Gaist, David

    Published in European journal of clinical pharmacology (01-02-2014)
    “…Purpose To determine the degree of long-term non-persistence to antiplatelet drugs in patients with transient ischaemic attack (TIA) and identify determinants…”
    Get full text
    Journal Article
  8. 8

    Discontinuation of antiplatelet treatment and risk of recurrent stroke and all-cause death: a cohort study by Ostergaard, Kamilla, Pottegård, Anton, Hallas, Jesper, Bak, Søren, dePont Christensen, René, Gaist, David

    Published in Neuroepidemiology (01-01-2014)
    “…We wished to examine the impact of antiplatelet drug discontinuation on recurrent stroke and all-cause mortality. We identified a cohort of incident ischaemic…”
    Get more information
    Journal Article
  9. 9

    Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data by Østergaard, Kamilla, Hallas, Jesper, Bak, Søren, Christensen, René dePont, Gaist, David

    Published in European journal of clinical pharmacology (01-12-2012)
    “…Purpose Treatment with antiplatelet drugs is a key element of secondary stroke prevention. We investigated long-term antiplatelet drug use in stroke patients…”
    Get full text
    Journal Article
  10. 10

    No effect of ablation of surfactant protein-D on acute cerebral infarction in mice by Lambertsen, Kate L, Østergaard, Kamilla, Clausen, Bettina H, Hansen, Søren, Stenvang, Jan, Thorsen, Stine B, Meldgaard, Michael, Kristensen, Bjarne W, Hansen, Pernille B, Sorensen, Grith L, Finsen, Bente

    Published in Journal of neuroinflammation (19-07-2014)
    “…Crosstalk between the immune system in the brain and the periphery may contribute to the long-term outcome both in experimental and clinical stroke. Although,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13